Table 1.
n | % | Age, year | Size, mm | Female, % | White nonH, % | Black nonH, % | Asian/PI, % | Hispanic, % | OS, % | Pathology confirm,% | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
||||||||||||
Median | IQR | Median | IQR | 60 mos | 95 %CI | |||||||||
Total | 113,349 | 100.0 | 53 | (39–65) | 18 | (9–27) | 53.0 | 64.3 | 19.9 | 3.7 | 10.1 | 89.0 | (88.7–89.2) | 58.7 |
Pituitary adenoma | 106,535 | 94.0 | 53 | (39–66) | 18 | (9–26) | 53.0 | 64.2 | 19.9 | 3.7 | 10.2 | 89.7 | (89.5–89.9) | 57.7 |
Craniopharyngioma | 4,307 | 3.8 | 52 | (40–63) | 26 | (19–34) | 51.6 | 65.3 | 20.4 | 3.9 | 8.5 | 78.0 | (76.5–79.3) | 85.3 |
Uncommon tumor types | 799 | 0.7 | 55 | (42–68) | 23 | (17–31) | 52.2 | 69.5 | 15.7 | 4.6 | 8.3 | 74.2 | (70.7–77.4) | 84.6 |
Tumor type not determined | 1,708 | 1.5 | 55 | (41–70) | 17 | (10–25) | 55.0 | 65.7 | 20.6 | 2.8 | 8.9 | 79.2 | (76.9–81.3) | 36.5 |
IQR interquartile range, nonH non-Hispanic, OS overall survival, CI confdence interval